Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

LYEL

Lyell Immunopharma, Inc.

Healthcare · USD

Set alert

Price alert · LYEL

All alert types
11.04 USD -0.27 -2.34%
As of Oct 30, 2026 Extended hours 11.04 0.00%
Bid
11.00 × 2
Ask
11.04 × 2
10.80 Day range 11.40
7.51 52-week range 38.60
YTD
-64.13%
1 year
-33.21%
Open
11.26
Prev close
11.31
Mkt cap
270.54M
Vol
113.26K
Avg vol
151.31K
EPS
-12.86
P/E
0.00
Div yield
0.00%
More statistics
Low
10.80
High
11.40
Forward P/E
-0.73
Beta
-0.48
Short ratio
6.15
Inst. own
58.79%
Dividend
0.00
Ex-div date
50-d avg
1.01
200-d avg
1.68
1y target
1.00

5D chart

Chart tools
Interval
1m5m15m30m
LYEL five-day price chart9.059.6910.311.011.6Oct 23Oct 26Oct 28Oct 29

Financial health

Altman Z-Score

-7.46 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -1.9×
FY 2019: -638×FY 2020: -400×FY 2021: -150×FY 2022: -93.6×FY 2023: -41.5×FY 2024: -9.8×FY 2025: -1.9×
FY 2019 5y median -41.5× FY 2025
P/S 14615×
FY 2019: 6339×FY 2020: 537×FY 2021: 176×FY 2022: 10.1×FY 2023: 3745×FY 2024: 2743×FY 2025: 14615×
FY 2019 5y median 2743× FY 2025
P/B 2.1×
FY 2019: 10.2×FY 2020: 5.8×FY 2021: 2.0×FY 2022: 1.0×FY 2023: 0.7×FY 2024: 0.4×FY 2025: 2.1×
FY 2019 5y median 1.0× FY 2025
P/FCF -3.5×
FY 2019: 178×FY 2020: -19.6×FY 2021: -9.8×FY 2022: -4.4×FY 2023: -2.9×FY 2024: -1.0×FY 2025: -3.5×
FY 2019 5y median -3.5× FY 2025
EV/EBITDA -2.0×
FY 2019: -40.6×FY 2020: -18.9×FY 2021: -7.0×FY 2022: -4.9×FY 2023: -1.9×FY 2024: -0.6×FY 2025: -2.0×
FY 2019 5y median -2.0× FY 2025
EV/Sales 14359×
FY 2019: 6234×FY 2020: 526×FY 2021: 155×FY 2022: 9.5×FY 2023: 3111×FY 2024: 1979×FY 2025: 14359×
FY 2019 5y median 1979× FY 2025
FCF Yield -28.7%
FY 2019: 0.6%FY 2020: -5.1%FY 2021: -10.2%FY 2022: -22.6%FY 2023: -34.2%FY 2024: -97.3%FY 2025: -28.7%
FY 2019 5y median -28.7% FY 2025

Profitability

Gross Margin -31952.8%
FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: -31952.8%
FY 2019 5y median 100.0% FY 2025
Operating Margin -566038.9%
FY 2019: -15538.7%FY 2020: -2732.6%FY 2021: -2016.7%FY 2022: -220.9%FY 2023: -190006.2%FY 2024: -588123.0%FY 2025: -566038.9%
FY 2019 5y median -190006.2% FY 2025
Net Margin -762355.6%
FY 2019: -19692.1%FY 2020: -2636.3%FY 2021: -2349.5%FY 2022: -216.2%FY 2023: -180486.2%FY 2024: -562285.2%FY 2025: -762355.6%
FY 2019 5y median -180486.2% FY 2025
ROE -110.6%
FY 2019: -31.7%FY 2020: -28.5%FY 2021: -26.9%FY 2022: -22.0%FY 2023: -35.8%FY 2024: -89.6%FY 2025: -110.6%
FY 2019 5y median -35.8% FY 2025
ROIC -68.0%
FY 2019: -19.1%FY 2020: -24.6%FY 2021: -19.9%FY 2022: -20.7%FY 2023: -34.2%FY 2024: -80.6%FY 2025: -68.0%
FY 2019 5y median -34.2% FY 2025
ROA -80.7%
FY 2019: -23.3%FY 2020: -22.5%FY 2021: -22.2%FY 2022: -19.5%FY 2023: -31.3%FY 2024: -69.9%FY 2025: -80.7%
FY 2019 5y median -31.3% FY 2025

Growth (YoY)

Revenue -41.0%
FY 2019: 0.0%FY 2020: 1080.5%FY 2021: 37.3%FY 2022: 695.1%FY 2023: -99.8%FY 2024: -53.1%FY 2025: -41.0%
FY 2019 FY 2025
Operating Income 43.2%
FY 2019: 0.0%FY 2020: -107.6%FY 2021: -1.3%FY 2022: 12.9%FY 2023: -32.0%FY 2024: -45.2%FY 2025: 43.2%
FY 2019 FY 2025
EPS (diluted) -1126.0%
FY 2019: 0.0%FY 2020: -59.4%FY 2021: -22.2%FY 2022: 28.1%FY 2023: -26.1%FY 2024: -40.1%FY 2025: -1126.0%
FY 2019 FY 2025
Free Cash Flow 7.4%
FY 2019: 0.0%FY 2020: -1006.5%FY 2021: 9.7%FY 2022: -1.1%FY 2023: 14.2%FY 2024: 2.1%FY 2025: 7.4%
FY 2019 FY 2025

Financial Health

Current Ratio 5.3×
FY 2019: 20.0×FY 2020: 12.5×FY 2021: 13.4×FY 2022: 17.6×FY 2023: 16.1×FY 2024: 7.1×FY 2025: 5.3×
FY 2019 5y median 13.4× FY 2025
Quick Ratio 5.3×
FY 2019: 20.0×FY 2020: 12.5×FY 2021: 13.4×FY 2022: 17.6×FY 2023: 16.1×FY 2024: 7.1×FY 2025: 5.3×
FY 2019 5y median 13.4× FY 2025
Debt / Equity 0.2×
FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2019: 0.7×FY 2020: 0.4×FY 2021: 1.0×FY 2022: 0.3×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 0.0×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2019 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31